Clinical Trial Update: Safety Study of Polylactide-Caprolactone-Trimethylenecarbonate Copolymer for Post-Operative Adhesion Prophylaxis [Phase 1]

View source ↗

Summary

Phase 1 safety study of a polylactide-caprolactone-trimethylenecarbonate copolymer for preventing postoperative adhesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Adhesions

Drugs mentioned

• Polylactide-Caprolactone-Trimethylenecarbonate Copolymer (polylactide-caprolactone-trimethylenecarbonate copolymer)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Adhesions | Phase 1 | Status: COMPLETED